Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Sodium intake and high blood pressure among adults on caloric restriction: a multi-year cross-sectional analysis of the U.S. Population, 2007-2018

View ORCID ProfileJorge Andrés Delgado-Ron, View ORCID ProfilePatricio López-Jaramillo, View ORCID ProfileMohammad Ehsanul Karim
doi: https://doi.org/10.1101/2020.12.27.20248919
Jorge Andrés Delgado-Ron
1School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jorge Andrés Delgado-Ron
  • For correspondence: andres{at}delgado.ec jorge.delgadoron{at}ubc.ca
Patricio López-Jaramillo
2Instituto Masira, Medical School, Universidad de Santander (UDES), Bucaramanga, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Patricio López-Jaramillo
Mohammad Ehsanul Karim
1School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada
3Centre for Health Evaluation and Outcome Sciences (CHEOS), St. Paul’s Hospital, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mohammad Ehsanul Karim
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract and Keywords

Aim Small studies have shown reduced sodium sensitivity of blood pressure in obese adolescents on caloric restriction. However, no study at the population level has studied such an effect. We aimed to explore the association between mean daily sodium intake and prevalent hypertension among a nationally representative sample of U.S. adults on caloric restriction who participated in the National Health Examination and Nutrition Survey over the last twelve years.

Methods and Results We used a design-based regression model to explore the association between sodium intake and prevalent hypertension. We also conducted sensitivity analyses using multiple imputation chained equations and propensity score matching. We also measured the effect of a binary exposure derived from two widely recommended thresholds of sodium intake: 2.3 and 5.0 grams per day. Among 5,756 individuals, we did not detect any significant association between increased sodium and the odds of hypertension (OR: 0.97; CI 95%: 0.90; 1.05). All our sensitivity analyses are consistent with our main findings.

Conclusion Our findings suggest that people on caloric restriction—a component of healthy weight loss—would see no benefit in reducing sodium intake to lower blood pressure. These results highlight the need to explore new population-specific strategies for sodium intake reduction, including new dietary prescription approaches to improve dietary adherence and reduce the risk associated with sodium-deficient diets.

Introduction

Hypertension causes more death and disability than any other risk factor globally, ahead of smoking, high glucose, and obesity. Nearly 10.4 million deaths worldwide were attributable to elevated blood pressure in 2017.1 Ambard and Beaujard theorized a potential association between salt consumption and hypertension as early as 1904. However, contradictory evidence from observational studies using low-salt diets led to an intense debate that lasted more than a century.2 Only recently, well-designed clinical trials provided reliable answers. The Dietary Approaches to Stop Hypertension-Sodium (DASH-Na) trial concluded that “blood pressure can be lowered … by reducing the sodium intake.”3 Long-term cohort studies support the DASH-Na trial findings.4

The precise mechanisms that cause dietary sodium to modulate blood pressure levels are not well defined, which often translates to uncertainty about who would benefit from such interventions. Past studies have shown the role of specific modifiers like ethnicity, even at the molecular level.5 However, we know much less about the role of energy balance—the equilibrium between calories consumed and calories burned through physical activity6—as a modifier of “salt sensitivity” of blood pressure.

Energy balance is arguably a more critical modifier than diet or exercise on their own. After all, we reach metabolic tipping points that enable our bodies to regulate blood pressure through the additive interaction of energy intake and energy expenditure.7,8 Current studies lack this holistic understanding and, as a result, present somehow conflictive evidence. For instance, a reanalysis of the DASH-Na data found less energy intake associated with increased salt sensitivity.9 Similarly, a community-based study in China found that participants in the highest quartile of physical activity had reduced salt sensitivity compared to the lowest quartile. However, there was not a linear association across quartiles.10

Caloric restriction and fitness are recommended to prevent or control hypertension.11,12 The current European and American hypertension guidelines recommend a reduced sodium intake on top of that.13,14 However, it is not clear if patients would benefit from reducing sodium in their diet once they are on an energy deficit. Caloric restriction—a negative energy balance—reduces blood pressure levels through improved insulin sensitivity, reduced adiposity, and reduced sympathetic activity, independent of reaching an ideal body weight.15,16 These mechanisms might also play a role in modulating the salt sensitivity of blood pressure.12,17 Studies that induced weight loss have modified the relationship between sodium and blood pressure. However, they used small samples and are outdated.16,18

In the present work, we used a design-based regression model to explore the association between mean daily sodium intake and prevalent hypertension among U.S. adults on caloric restriction in the National Health Examination and Nutrition Survey (NHANES) from 2007 to 2018.

Methods

Data source, Design, and Study Population

We used publicly available data from NHANES, a cross-sectional four-stage stratified cluster complex survey, representative of the non-institutionalized United States population. NHANES gathers lifestyle and medical information, along with biological samples and a physical examination. Readers can find relevant description design and sampling procedures associated with this survey elsewhere.19 The study complies with the Declaration of Helsinki and it is covered by item 7.10.3 in the University of British Columbia’s Policy 89 on studies involving human participants and Article 2.2 in the Tri-Council Policy Statement Ethical Conduct for Research Involving Humans.

Analytic sample and study variables

We included adults aged 20-79 years from six two-year cycles (2007-2018) with an energy deficit of at least -350 calories per day. We chose this cut-off to correct potential underreporting from self-reported dietary data.20 We derived energy balance from its two essential components: energy input (mean daily intake) and energy output (basal metabolic rate plus physical activity).6 The basal metabolic rate was calculated using the revised Harris-Benedict equations.21 Self-reported weekly vigorous and moderate physical activity was transformed into daily metabolic equivalents following NHANES’ suggested scores.22 NHANES derives the total daily intake from two 24-hour recall interviews, 3 to 10 days apart, using a validated instrument to reduce recall bias.23 We did not exclude participants with invalid or missing answers for physical activity; instead, we used their basal metabolic rate as total output.

We excluded pregnant women and participants with body mass index (BMI) below 18.5 (malnutrition) or an active thyroid pathology due to inherent metabolic differences in these patients. Adults over the age of 80 were excluded because their age is not publicly available due to privacy concerns. We also excluded people who reported a “much less than usual” intake during either interview.

The primary outcome was hypertension, a binary variable indicating one of the following: self-reported use of antihypertensive medication or systolic hypertension (mean systolic blood pressure ≥ 130 mmHg) or diastolic hypertension (diastolic blood pressure ≥ 80 mmHg).11 Individuals without a second valid measurement for either systolic (SBP) or diastolic blood pressure (DBP) were excluded to avoid measurement error.

The exposure was self-reported mean consumption of sodium (grams per day) as a continuous measure. Two additional binary variables were derived for our sensitivity analyses (described later). Other covariates included demographic data (age, gender, education, income, and ethnicity), pre-existing diseases (diabetes and obesity), and smoking.24 We excluded “Refused,” “Don’t know,” and “Missing” values for demographic variables. However, for diabetes, we required respondents to provide a definitive “Yes.” The details of the analytic data creation process are shown in Figure 1.

Figure 1.
  • Download figure
  • Open in new tab
Figure 1.

Flow chart of the analytic sample selection for testing the association between sodium intake and high blood pressure among U.S. adults on caloric restriction aged 20-79, using data from the National Health and Nutrition Examination Survey; cycles 2007-2008 to 2017-2018.

Figure 2 depicts our hypothesized causal diagram describing the causal relationships among the variables under consideration. Given we already restricted the sample by energy balance, we minimized bias adjusting for age, diabetes, education, ethnicity, gender, energy expenditure, BMI, and smoking status based solely on Pearls’ backdoor criterion.25 Serum sodium and the renin-angiotensin-aldosterone system (unmeasured) were assumed mediators. Other unmeasured variables include alcohol consumption and fat accumulation.

Figure 2.
  • Download figure
  • Open in new tab
Figure 2.

Directed acyclic graph for assessing the causal association between sodium intake and elevated blood pressure. Considering our energy balance restriction, age, gender, ethnicity, education, income, and total intake act as confounders. We achieved sufficient adjustment by controlling age, diabetes, education, ethnicity, gender, energy expenditure, body mass index, and smoking status. Fat accumulation, alcohol, and the renin-angiotensin-aldosterone system (RAAS) are unmeasured variables. Serum sodium and RAAS are mediators. The figure was drawn using the web-version of DAGitty.

Primary Analysis

We compared individuals’ characteristics by hypertension status (yes/no) using survey-featured t-tests for continuous variables and the Rao-Scott F-adjusted χ2 test for categorical variables.26 We combined the survey weights from our six cross-sectional subsamples following NHANES recommendations19 and built our design using all survey features, subsetting only the eligible sample. We estimated the Odds Ratio (OR) and respective confidence intervals (CI 95%) using a design-based multivariate logistic regression (hereafter referred to as the ‘outcome model’), adjusting for the variables selected based on Pearls’ backdoor criterion as described above.

We probed interactions between sodium intake and the other covariates using Bauer’s inferential and graphical techniques27 based on findings from the previous literature.9 Collinearity was assessed via variance inflation factors (VIF) and classified following the recommendations by Belsley.28

The goodness of fit for all models was evaluated using weighted ROC curves and the Archer-Lemeshow test.29,30 All 95% confidence intervals (CI) and Cox-Snell pseudo-R2 account for both the survey design and day-to-day dietary intake variations.19,31,32

Sensitivity Analyses

Missing data

As missing completely at random assumption may not be realistic, we applied the multivariate imputation by chained equation method.33,34 We imputed 20 datasets under the missing at random assumption using all the variables from our primary analysis model as predictors for the imputation model. Rubin’s rules were used to pool the estimates together.34

Binary exposure based on recommended thresholds

We transformed the exposure in our outcome model to a binary variable. First, we used the threshold of ≥ 2.3 g/day to classify exposure as “high” or “low,” following the maximum sodium intake recommendations in current European and American hypertension guidelines.13,14 Then, we used a threshold of ≥ 5.0 g/day, the daily sodium intake recommended by the World Health Organization,35 using the same specifications described below.

We performed the analysis with both the complete-case dataset and the imputed datasets, pooling the estimates as described above. We also matched the probability of being exposed to “high” or “low” sodium intake using propensity scores for both thresholds. We performed a 1:1 nearest neighbour match (without replacement) on the propensity score’s logit with a 0.2 calliper.36 We modelled the exposure using our original covariates—cycle and survey features were also covariates following Dugoff’s method37—to achieve adequate standardized mean difference balance (SMD < 0.2). The survey-featured outcome model was used to estimate the population average treatment effect from the matched subsample. Again, the exposure was binary (“high” vs. “low”).

All statistical analyses were performed using R 4.0.3;38 the code is available on request.

Results

Study sample characteristics

We evaluated a total of 5,756 individuals, representing a U.S. national population of 53,036,129. The weighted prevalence of hypertension in our sample was 42.6%. On average, hypertensive individuals were significantly more likely to be male, older, diabetic, and overweight or obese. Hypertensive and non-hypertensive people also differed significantly in ethnicity and smoking history, but not education or daily total energy expenditure. Sodium intake did not significantly differ by hypertension status (Table 1).

View this table:
  • View inline
  • View popup
Table 1.

Participants characteristics by hypertensive status, U.S. adults who reported caloric restriction aged 20-79. National Health and Nutrition Examination Survey (NHANES) 2007-2018.

Association between mean daily sodium intake and prevalent hypertension

A one-gram increase in daily sodium intake did not significantly correlate with higher odds of hypertension in the U.S. population on caloric restriction. The estimate was imprecise around the null in both the crude (OR=0.98, 95% CI: 0.93; 1.03) and adjusted models (Table 2). We did not find any significant interaction between the exposure and other covariates. Multicollinearity was “near weak” for all independent variables (VIF < 2.5).

View this table:
  • View inline
  • View popup
Table 2.

Survey-featured multivariable logistic regression model for the relationship between average daily sodium intake (grams per day) and hypertension among U.S. adults in caloric restriction, aged 20-79. National Health and Nutrition Examination Survey (NHANES) 2007-2018

Sensitivity analysis

Multiple imputations for missing data

Data for moderate and vigorous physical activity was missing for 30% of the sample. Other sampling variables with lower proportions of missing data were calorie intake (9%), height (8%), and the derived BMI (8%). Model variables with missingness were mean sodium intake (9%) and education (40.8%). Each imputed dataset contained approximately 6,326 observations. The estimate and confidence intervals were equal to that of the primary analysis (OR=0.97, 95% CI: 0.90; 1.05) (Table 2).

Sodium intake of ≥ 2.3 g/day

Consuming 2.3 grams of sodium per day or more was not significantly associated with higher hypertension odds in either the complete-case or imputed data analyses. Although both estimates found a different effect, they were imprecise around the significance threshold. Hence, we failed to find an association (Table 3).

View this table:
  • View inline
  • View popup
Table 3.

Survey-featured multivariable logistic regression model for the relationship between “high” and “low” daily sodium intake (threshold: ≥ 2.3 grams per day) and hypertension among U.S. adults in caloric restriction, aged 20-79 (National Health and Nutrition Examination Survey 2007-2018, complete-case, multiple imputations, and matched using the propensity score of the exposure.

The final propensity score for the probability of being exposed to higher amounts of sodium was estimated using age, gender, ethnicity, education, BMI (categorical), history of diabetes, history of smoking, energy expenditure, and survey features. After propensity-score matching, a total of 2,808 participants—representing a U.S. population of 24,340,468—were matched. Matching reduced the SMD to < 0.1 for all covariates, except for total daily energy expenditure (SMD = 0.27). Our outcome model corrected any remaining imbalances. The results, again, could not support an association between exposure and outcome (OR=0.99, 95% CI: 0.77; 1.27) (Table 3).

Sodium intake of ≥ 5.0 g/day

When the threshold for “high” sodium intake was 5 grams per day or more, the estimates did not change significantly for either the complete-case or the multiple imputation pool estimated. The lack of association, however, was accompanied by wider confidence intervals (Table 4).

We estimated the probability of being exposed to “high” sodium levels using the same model for both thresholds. A total of 926 participants—representing a U.S. population of 9,559,626—were matched by their propensity score. The SMD for all covariates was balanced (< 0.17). The binary outcome model showed no association between exposure and outcome (Table 4).

View this table:
  • View inline
  • View popup
Table 4.

Survey-featured multivariable logistic regression model for the relationship between “high” and “low” daily sodium intake (threshold: ≥ 5.0 grams per day) and hypertension among U.S. adults in caloric restriction, aged 20-79 (National Health and Nutrition Examination Survey 2007-2018), complete-case, multiple imputations, and matched using the propensity score of the exposure.

Discussion

Main findings

Our analysis of a multi-year nationally representative sample of U.S. adults on caloric restriction did not detect any significant association between increased sodium consumption levels and the odds of hypertension (OR: 0.97; CI 95%: 0.90; 1.05). Our survey-featured logistic regression was adjusted by age, gender, ethnicity, education, BMI, diabetes, smoking, and total daily energy expenditure. Several sensitivity analyses yielded similar results, including those that analyzed two widely recommended sodium intake thresholds (≥2.3 and ≥5.0 grams per day). These results cement the need to target low-sodium interventions appropriately given its associated risks.39,40

Contextualizing the evidence

Very few studies had been able to identify a representative sample of participants on caloric restriction, commonly identified through healthy weight loss. Our findings suggest that people on caloric restriction would see no benefit in reducing sodium in their diet to lower blood pressure. These findings apply to the general U.S. adults and other populations with similar characteristics. Our findings align with previous reports in obese adolescents, who lost their “sensitivity of blood pressure to sodium” following a 20-week intervention to lose weight (through caloric restriction).18

Caloric restriction lowers blood pressure levels independent of other factors; it decreases body fat and, consequentially, increases insulin sensitivity.41 Insulin modulates the renal absorption of sodium. As a result, people on caloric restriction excrete more sodium than those in a caloric surplus, which might explain the loss of sodium sensitivity in these patients.42 Such effects can be seen within hours of fasting and had been recently hypothesized as mechanisms that regulate blood pressure levels in healthy and sick individuals.17,43,44 While these are acute effects, other cardiometabolic benefits of caloric restriction appear to be long-lasting.15 We highlight the need for a tailored approach for blood pressure control in this specific subpopulation. Laxer sodium intake recommendations for these patients could help mitigate the potential low adherence to a low sodium diet and its associated adverse effects (e.g. increased risk of death).39,40,45 They could also reduce the complexity of dietary interventions and increase their palatability, which is paramount to improving adherence and achieving successful weight reduction.46

Strengths and limitations

Our study benefited from using a population-level sample, with an adequate representation of people from diverse ethnicities, ages, and socioeconomic characteristics. Our analysis used survey features, which allowed us to generalize our findings to all the non-institutional U.S. adult population going through a healthy weight loss. We restricted our sample to participants on caloric restriction, therefore addressing the ambiguities of metabolically healthy obese patients and lean people who exhibit obese-like characteristics (dyslipidemia, altered inflammatory profile, and increased fat cell size).47,48 Rarely do hypertension studies account for such ambiguity. Our findings were robust under the missing at random assumption and to adjustments to the exposure to recommended intake levels by American and European current guidelines and the World Health Organization guidelines.

Our study has several limitations. We used self-reported data for energy intake, prone to measurement bias and underreporting. While our selected threshold20 for energy balance accounts for such underreporting, this measurement error is not systematic. We further tried to minimize bias by only including the observations marked as reliable by NHANES—providing a detailed description of each food, including the amount, additional ingredients, and eating occasions—and excluding all participants reporting a less than usual intake. NHANES interviewers also double-check to elicit forgotten foods, and the survey weights account for variation between weekends and weekdays.49

We also used self-reported sodium consumption instead of the 24-hour urinary collection (considered by many as the gold standard). We made this decision based on two arguments. Firstly, the Automated Multiple-Pass Method employed by NHANES provides reliable sodium and intake measures.23 Secondly, the hypothesized underlying mechanism (increased sodium retention) requires us to measure intake and not excretion.

Self-reported data for moderate and vigorous activity is not as reliable as objectively measured physical activity.50 If people reported more than 24 hours of physical and sedentary activity, NHANES analysts set those values to missing. We dealt with this first with two methods. Firstly, we took a conservative sampling (including the BMR as total energy expenditure whenever data was not available meant that participants who reported high activity levels were considered sedentary). Secondly, we used multiple imputations procedures under the assumption that these data, although not missing at random, could be predicted using the available variables.33 Statistically, there were no significant differences between the estimates obtained by either method. However, the direction of the effect changed with multiple imputations in both thresholds. Such a change of direction might reflect the effect of the omitted physical activity in the complete-case sample. Nevertheless, the difference was not statistically significant. Finally, our cross-sectional design did not allow us to establish a temporal relationship between exposure and outcome. It’s feasible for people to modify their diet to cope with their disease.

Conclusion

Our findings showed that sodium intake was not associated with higher odds of hypertension among the U.S. population on caloric restriction. Our results were robust to missing data and different representations of the exposure, disputing a low-salt diet’s benefits for people who achieve weight loss and maintain it using caloric restriction. These results highlight the need to explore new population-specific strategies for sodium intake reduction, including new dietary prescription approaches that improve adherence and reduce the risk associated with deficient sodium diets.

Data Availability

We used publicly available data from the National Health Examination and Nutrition Survey (2007-2018). R Code is available under request.

https://wwwn.cdc.gov/nchs/nhanes/

Disclosure

Funding

none declared.

Conflict of interest

Dr. Karim reports grants from BC SUPPORT Unit, grants from Michael Smith Foundation for Health Research, grants from Natural Sciences and Engineering Research Council of Canada, personal fees from Biogen Inc., outside the submitted work.

References

  1. 1.↵
    GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Stu. Lancet (London, England) 2018;392:1923–1994.
    OpenUrl
  2. 2.↵
    DiNicolantonio JJ, O’Keefe JH. The History of the Salt Wars. Am J Med Elsevier Inc; 2017;130:1011–1014.
    OpenUrl
  3. 3.↵
    Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER, Simons-Morton DG, Karanja N, Lin P-H, Aickin M, Most-Windhauser MM, Moore TJ, Proschan MA, Cutler JA. Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet. N Engl J Med Massachusetts Medical Society; 2001;344:3–10.
    OpenUrl
  4. 4.↵
    Mente A, O’Donnell M, Rangarajan S, McQueen M, Dagenais G, Wielgosz A, Lear S, Ah STL, Wei L, Diaz R, Avezum A, Lopez-Jaramillo P, Lanas F, Mony P, Szuba A, Iqbal R, Yusuf R, Mohammadifard N, Khatib R, Yusoff K, Ismail N, Gulec S, Rosengren A, Yusufali A, Kruger L, Tsolekile LP, Chifamba J, Dans A, Alhabib KF, Yeates K, et al. Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study. Lancet Elsevier Ltd; 2018;392:496–506.
    OpenUrl
  5. 5.↵
    He FJ, Markandu ND, Sagnella GA, MacGregor GA. Importance of the Renin System in Determining Blood Pressure Fall With Salt Restriction in Black and White Hypertensives. Hypertension American Heart Association; 1998;32:820–824.
    OpenUrl
  6. 6.↵
    Hall KD, Heymsfield SB, Kemnitz JW, Klein S, Schoeller DA, Speakman JR. Energy balance and its components: implications for body weight regulation. Am J Clin Nutr American Society for Nutrition; 2012;95:989–994.
    OpenUrl
  7. 7.↵
    Hinderliter AL, Babyak MA, Sherwood A, Blumenthal JA. The DASH diet and insulin sensitivity. Curr Hypertens Rep 2011;13:67–73.
    OpenUrlCrossRefPubMed
  8. 8.↵
    Archer E, Lavie CJ, Hill JO. The Contributions of ‘Diet’ ‘Genes’ and Physical Activity to the Etiology of Obesity: Contrary Evidence and Consilience. Prog Cardiovasc Dis Elsevier Inc.; 2018;61:89–102.
    OpenUrl
  9. 9.↵
    Murtaugh MA, Beasley JM, Appel LJ, Guenther PM, McFadden M, Greene T, Tooze JA. Relationship of sodium intake and blood pressure varies with energy intake: Secondary analysis of the DASH (Dietary Approaches to Stop Hypertension)-sodium Trial. Hypertension 2018;71:858–865.
    OpenUrl
  10. 10.↵
    Rebholz CM, Gu D, Chen J, Huang J-F, Cao J, Chen J-C, Li J, Lu F, Mu J, Ma J, Hu D, Ji X, Bazzano LA, Liu D, He J, Group for the GCR. Physical Activity Reduces Salt Sensitivity of Blood Pressure: The Genetic Epidemiology Network of Salt Sensitivity Study. Am J Epidemiol 2012;176:S106–S113.
    OpenUrlCrossRefPubMed
  11. 11.↵
    Whelton PK, Carey RM, Aronow WS, Casey DEJ, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SCJ, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KAS, Williamson JD, Wright JTJ. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task. Hypertens (Dallas, Tex 1979) United States; 2018;71:1269–1324.
    OpenUrlCrossRefPubMed
  12. 12.↵
    Lechner K, Schunkert H. Recommendations on sodium intake for cardiovascular health: conviction or evidence? Eur Heart J 2020;41:1–2.
    OpenUrl
  13. 13.↵
    Jackson S, Cogswell M, Zhao L, Terry A, Wang C-Y, Wright J, Coleman King S, Bowman B, Chen T-C, Merritt R, Loria, Catherine. Association Between Urinary Sodium and Potassium Excretion and Blood Pressure Among Adults in the United States. Circulation American Heart Association; 2018;137:237–246.
    OpenUrl
  14. 14.↵
    Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, Simone G de, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J 2018;39:3021–3104.
    OpenUrlCrossRefPubMed
  15. 15.↵
    Kraus WE, Bhapkar M, Huffman KM, Pieper CF, Krupa Das S, Redman LM, Villareal DT, Rochon J, Roberts SB, Ravussin E, Holloszy JO, Fontana L. 2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial. Lancet Diabetes Endocrinol 2019;7:673–683.
    OpenUrl
  16. 16.↵
    Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwell M. The Effect of Weight Reduction on Blood Pressure, Plasma Renin Activity, and Plasma Aldosterone Levels in Obese Patients. N Engl J Med Massachusetts Medical Society; 1981;304:930–933.
    OpenUrl
  17. 17.↵
    Brands MW. Role of insulin-mediated antinatriuresis in sodium homeostasis and hypertension. Hypertension 2018;72:1255–1262.
    OpenUrl
  18. 18.↵
    Rocchini AP, Key J, Bondie D, Chico R, Moorehead C, Katch V, Martin M. The Effect of Weight Loss on the Sensitivity of Blood Pressure to Sodium in Obese Adolescents. N Engl J Med Massachusetts Medical Society; 1989;321:580–585.
    OpenUrl
  19. 19.↵
    Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Questionnaire. Dep. Heal. Hum. Serv. Centers Dis. Control Prev. 2020. https://wwwn.cdc.gov/nchs/nhanes/ (9 October 2020)
  20. 20.↵
    Archer E, Hand GA, Blair SN. Validity of U.S. Nutritional Surveillance: National Health and Nutrition Examination Survey Caloric Energy Intake Data, 1971-2010. PLoS One 2013;8:1– 12.
    OpenUrlCrossRefPubMed
  21. 21.↵
    Roza AM, Shizgal HM. The Harris Benedict equation reevaluated: resting energy requirements and the body cell mass. Am J Clin Nutr 1984;40:168–182.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    Jetté M, Sidney K, Blümchen G. Metabolic equivalents (METS) in exercise testing, exercise prescription, and evaluation of functional capacity. Clin Cardiol 1990;13:555–565.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    Rhodes DG, Murayi T, Clemens JC, Baer DJ, Sebastian RS, Moshfegh AJ. The USDA Automated Multiple-Pass Method accurately assesses population sodium intakes. Am J Clin Nutr 2013;97:958–964.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    Ford ES, Cooper RS. Risk factors for hypertension in a national cohort study. Hypertension 1991;18:598–606.
    OpenUrl
  25. 25.↵
    Textor J, Zander B van der, Gilthorpe MS, Liśkiewicz M, Ellison GT. Robust causal inference using directed acyclic graphs: The R package ‘dagitty’. Int J Epidemiol 2016;45:1887–1894.
    OpenUrlPubMed
  26. 26.↵
    Rao JNK, Scott AJ. On chi-squared tests for multiway contingency tables with cell proportions estimated from survey data. Ann Stat JSTOR; 1984;12:46–60.
    OpenUrl
  27. 27.↵
    Bauer DJ, Curran PJ, Thurstone LL. Probing interactions in fixed and multilevel regression: Inferential and graphical techniques. Multivariate Behav Res 2005;40:373–400.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    Belsley DA. Assessing the presence of harmful collinearity and other forms of weak data through a test for signal-to-noise. J Econom 1982;20:211–253.
    OpenUrl
  29. 29.↵
    Archer KJ, Lemeshow S. Goodness-of-fit test for a logistic regression model fitted using survey sample data. Stata J 2006;6:97–105.
    OpenUrlWeb of Science
  30. 30.↵
    Hocking TD. Weighted ROC analysis. 2017;1:1–2.
    OpenUrl
  31. 31.↵
    Koch GG, Freeman Jr DH, Freeman JL. Strategies in the multivariate analysis of data from complex surveys. Int Stat Rev Int Stat JSTOR; 1975;59–78.
  32. 32.↵
    Lumley T. Pseudo-R2 statistics under complex sampling. Aust New Zeal J Stat 2017;59:187– 194.
    OpenUrl
  33. 33.↵
    Sterne JAC, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009;338:b2393.
    OpenUrlFREE Full Text
  34. 34.↵
    Zhang Z. Multiple imputation with multivariate imputation by chained equation (MICE) package. Ann Transl Med AME Publications; 2016;4:30.
    OpenUrl
  35. 35.↵
    World Health Organization. Guideline: sodium intake for adults and children. World Heal. Organ. Geneva: World Health Organization; 2012.
  36. 36.↵
    Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat 2011;10:150– 161.
    OpenUrlCrossRefPubMed
  37. 37.↵
    Dugoff EH, Schuler M, Stuart EA. Generalizing observational study results: applying propensity score methods to complex surveys. Health Serv Res Blackwell Publishing Ltd; 2014;49:284–303.
    OpenUrl
  38. 38.↵
    R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria; 2020.
  39. 39.↵
    McCarron DA, Geerling JC, Alderman MH. Urinary sodium excretion measures and health outcomes. Lancet Elsevier Ltd; 2019;393:1294–1295.
    OpenUrl
  40. 40.↵
    O’Donnell M, Mente A, Alderman MH, Brady AJB, Diaz R, Gupta R, López-Jaramillo P, Luft FC, Lüscher TF, Mancia G, Mann JFE, McCarron D, McKee M, Messerli FH, Moore LL, Narula J, Oparil S, Packer M, Prabhakaran D, Schutte A, Sliwa K, Staessen JA, Yancy C, Yusuf S. Salt and cardiovascular disease: insufficient evidence to recommend low sodium intake. Eur Heart J 2020;41:3363–3373.
    OpenUrl
  41. 41.↵
    Nicoll R, Henein MY. Caloric restriction and its effect on blood pressure, heart rate variability and arterial stiffness and dilatation: A review of the evidence. Int J Mol Sci 2018;19:1–18.
    OpenUrlCrossRefPubMed
  42. 42.↵
    Nakano Y, Oshima T, Sasaki S, Higashi Y, Ozono R, Takenaka S, Miura F, Hirao H, Matsuura H, Chayama K, Kambe M. Calorie restriction reduced blood pressure in obesity hypertensives by improvement of autonomic nerve activity and insulin sensitivity. J Cardiovasc Pharmacol 2001;38:s69–s74.
    OpenUrl
  43. 43.↵
    Sigler MH. The mechanism of the natriuresis of fasting. J Clin Invest 1975;55:377–387.
    OpenUrlCrossRefPubMedWeb of Science
  44. 44.↵
    Heyman SN, Bursztyn M, Szalat A, Muszkat M, Abassi Z. Fasting-Induced Natriuresis and SGLT: A New Hypothesis for an Old Enigma. Front Endocrinol (Lausanne) Frontiers Media S.A.; 2020;11:217.
    OpenUrl
  45. 45.↵
    Messerli FH, Hofstetter L, Syrogiannouli L, Rexhaj E, Siontis GCM, Seiler C, Bangalore S. Sodium intake, life expectancy, and all-cause mortality. Eur Heart J 2020;
  46. 46.↵
    Åberg G, Edman G, Rössner S. Perceived hunger, palatability, and adherence: A comparison of high- and low-fat diets. Obes Res Clin Pract 2008;2:101–110.
    OpenUrl
  47. 47.↵
    Ding C, Chan Z, Magkos F. Lean, but not healthy: the ‘metabolically obese, normal-weight’ phenotype. Curr Opin Clin Nutr Metab Care England; 2016;19:408–417.
    OpenUrl
  48. 48.↵
    Stefan N, Häring H-U, Hu FB, Schulze MB. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol England; 2013;1:152–162.
    OpenUrl
  49. 49.↵
    Ahluwalia N, Dwyer J, Terry A, Moshfegh A, Johnson C. Update on NHANES dietary data: Focus on collection, release, analytical considerations, and uses to inform public policy. Adv Nutr 2016;7:121–134.
    OpenUrlAbstract/FREE Full Text
  50. 50.↵
    Prince SA, Adamo KB, Hamel ME, Hardt J, Connor Gorber S, Tremblay M. A comparison of direct versus self-report measures for assessing physical activity in adults: A systematic review. Int J Behav Nutr Phys Act 2008;5.
Back to top
PreviousNext
Posted January 02, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Sodium intake and high blood pressure among adults on caloric restriction: a multi-year cross-sectional analysis of the U.S. Population, 2007-2018
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Sodium intake and high blood pressure among adults on caloric restriction: a multi-year cross-sectional analysis of the U.S. Population, 2007-2018
Jorge Andrés Delgado-Ron, Patricio López-Jaramillo, Mohammad Ehsanul Karim
medRxiv 2020.12.27.20248919; doi: https://doi.org/10.1101/2020.12.27.20248919
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Sodium intake and high blood pressure among adults on caloric restriction: a multi-year cross-sectional analysis of the U.S. Population, 2007-2018
Jorge Andrés Delgado-Ron, Patricio López-Jaramillo, Mohammad Ehsanul Karim
medRxiv 2020.12.27.20248919; doi: https://doi.org/10.1101/2020.12.27.20248919

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Cardiovascular Medicine
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)